How to Evaluate a Compounding Pharmacy

What PCAB accreditation actually means, how to read a certificate of analysis, and the quality markers that distinguish a reliable compounding pharmacy from a questionable one.

Why the Compounding Pharmacy Matters More Than You Think

Every peptide you receive through a telehealth provider comes from a compounding pharmacy. That’s not incidental—it’s the entire chain. Your provider writes the prescription, the pharmacy compounds (mixes and prepares) your peptide, and then you receive it. If the pharmacy fails, nothing else in that chain matters.

The problem is that compounding pharmacies are not all equivalent in quality. Two pharmacies might both be state-licensed and legal, but one might produce a product that is precisely what you paid for—correct identity, exact concentration, confirmed purity—while the other might produce something that looks right on the outside but is actually subpotent, contaminated, or something else entirely. You would have no way to know without testing.

This isn’t theoretical risk. In 2012, the New England Compounding Center (a state-licensed pharmacy) contaminated batches of preservative-free methylprednisolone with a fungal pathogen. The result: a meningitis outbreak affecting multiple states, 76 deaths, hundreds of infections. Pharmacy quality is not a luxury—it’s foundational patient safety. A bad compounder can cause serious harm.

When you’re evaluating a telehealth provider, evaluating the compounding pharmacy should be a non-negotiable part of your due diligence. This guide shows you how.

The Regulatory Framework: 503A vs. 503B

U.S. compounding pharmacies operate under two distinct regulatory categories, each with different oversight levels and quality requirements.

503A Pharmacies: Traditional Compounding

A 503A pharmacy is a traditional state-licensed pharmacy that compounds medications for individual patients under specific prescriptions. This is the original model of compounding—a pharmacist receives a prescription from a doctor for Patient X, and compounds that medication specifically for that patient. No advance compounding, no inventory stockpiling.

503A pharmacies are regulated primarily by state pharmacy boards, not by the FDA. The FDA’s involvement is indirect: it sets standards for which bulk drug substances are eligible for compounding, and it can take action against a pharmacy if compounded products are adulterated or misbranded. But day-to-day operations, inspections, and licensing are handled at the state level.

503B Outsourcing Facilities: Larger-Scale Operations

A 503B “outsourcing facility” is a registered facility that compounds medications without an individual patient prescription—meaning it can manufacture products in advance for office stock or for later dispensing. 503B facilities are FDA-registered and FDA-inspected. They must comply with current good manufacturing practice (cGMP)—the same standards pharmaceutical manufacturers follow.

The practical difference: 503B facilities have FDA oversight and must meet manufacturing standards that exceed what a typical 503A pharmacy requires. They also have to provide much more documentation about their manufacturing processes, quality controls, and testing protocols.

What does this mean for you? If your telehealth provider uses a 503B facility, you know that facility has FDA scrutiny and cGMP requirements built in. If they use a 503A pharmacy, that doesn’t automatically mean poor quality—many excellent 503A pharmacies exist—but it does mean you have less third-party verification. A 503A pharmacy is regulated by the state, not the FDA, which means you need to do more homework yourself to assess quality.

For more context on how FDA regulation works for compounded peptides, see FDA and WADA Regulatory Status.

PCAB Accreditation: What It Actually Means

PCAB stands for Pharmacy Compounding Accreditation Board, a subsidiary of the American Commission on Health Care Accreditation (ACHC). PCAB is a third-party accreditation program—similar to accreditation bodies in other industries—that audits and certifies compounding pharmacies against a set of standards that exceed minimum state requirements.

Key Point: PCAB Is Voluntary, Not Required

There is no law in any state that requires a compounding pharmacy to be PCAB-accredited. It is entirely voluntary. Some pharmacies pursue it, many do not. This is important because it means PCAB accreditation is a signal—a pharmacy chose to submit to additional third-party scrutiny to demonstrate quality—but its absence does not mean the pharmacy is poor quality.

What PCAB Accreditation Requires

To earn and maintain PCAB accreditation, a pharmacy must demonstrate:

• A documented quality management system with written procedures for every compounding process
• Sterile compounding standards that meet or exceed USP (United States Pharmacopeia) requirements
• Personnel competency verification—proof that pharmacists and technicians are trained and qualified
• Ongoing quality testing of products, including sterility and potency assays
• Environmental monitoring of compounding areas to detect contamination
• Stability testing for products with assigned use-by dates beyond a certain threshold
• Complaint handling and adverse event reporting procedures

These standards go beyond what many state pharmacy boards require. In other words, PCAB accreditation is a proxy for “we maintain quality standards stricter than the legal minimum.”

How to Verify PCAB Accreditation

PCAB maintains a searchable directory of accredited pharmacies on their website. If your provider’s pharmacy claims PCAB accreditation, you can verify it in seconds. If they claim it and it’s not there, that’s a red flag.

Important caveat: Some excellent pharmacies choose not to pursue PCAB accreditation—perhaps because the cost doesn’t justify it for their business model, or they prefer a different quality assurance pathway. The absence of PCAB accreditation is not a disqualifier, but the presence of it is a strong positive signal.

State Pharmacy Board Oversight

Every compounding pharmacy in the United States, regardless of whether it’s 503A or 503B, must be licensed by the state pharmacy board. This is the baseline: no state license, no legal operation.

What State Boards Do

State pharmacy boards:

• Issue pharmacy licenses and set minimum operational standards
• Conduct periodic inspections of licensed pharmacies
• Investigate complaints from patients or healthcare providers
• Maintain public records of disciplinary actions, violations, and warning letters
• Set record-keeping and documentation requirements

The quality of state board oversight varies significantly. Some states (California, Texas, New York, Florida) have sophisticated compounding oversight programs with dedicated staff and frequent inspections. Other states have minimal oversight. If your pharmacy is in a state with robust board oversight, that’s a meaningful quality signal.

How to Check State Licensure and Violations

Every state pharmacy board operates a public lookup tool. You can search by pharmacy name, location, or license number. The record should show:

• Current license status (active, inactive, suspended, revoked)
• License expiration date
• Any disciplinary actions, violations, or warning letters
• Names of licensed pharmacists at the location

If a pharmacy’s license is suspended or revoked, or if there’s a history of significant violations, that’s disqualifying. Some minor violations are normal in any regulated industry, but a pattern of violations or recent serious infractions warrants caution.

The Certificate of Analysis: Your Quality Control Document

A Certificate of Analysis (CoA) is a document issued by the pharmacy (or more commonly by a third-party testing lab they use) that reports the results of quality testing performed on your product. It is the most concrete piece of evidence about what’s actually in your vial.

What a Complete CoA Should Contain

For a peptide product (injectable or otherwise), a proper CoA should include:

How to Read a CoA: What to Look For

When you request a CoA from your pharmacy or provider, here’s what to examine:

• Specific numerical results, not vague language. A CoA should say “Purity: 97.2% by HPLC” not “Passes purity specification.” It should say “Sterility: No growth detected” with a specific testing method referenced.
• Testing dates. When was the testing performed? Peptides degrade, so you want recent data—ideally within weeks of shipment.
• Lab credentials. Who performed the testing? Is it the pharmacy’s internal lab, a contract testing lab, or a third-party lab? A third-party lab provides more independence and credibility.
• Lot number matching. Does the lot number on the CoA match the lot number on your vial? If not, the CoA doesn’t prove anything about your product.
• Specification ranges. For each test, look for what the specification is (the acceptable range). Purity should be ≥95%, ideally ≥98%. Potency should be within ±10% of labeled amount. If results are outside spec but still reported, that’s a problem.

Red Flags in a CoA

• Missing sterility testing data for an injectable product
• Missing HPLC purity data, or purity below 95%
• Potency/concentration significantly different from label (more than ±10%)
• No specific numerical results—just checkmarks or “passes”
• Testing dates that are months old (suggest the product has been stored without care)
• No lot number, or lot number doesn’t match your vial
• Unexplained failed tests that were then “retested and passed”

For a deeper dive on CoA interpretation, see How to Read a Certificate of Analysis.

Beyond Potency Testing: The Gold Standard

A basic CoA confirms that a product is pure and contains the labeled concentration on the day it was tested. But there’s a gap: what about after you receive it? Peptides are unstable molecules—they degrade over time, especially if exposed to heat, light, or improper storage.

What Stability Testing Is

Stability testing is additional work a pharmacy can do to determine how long a product remains potent under specified storage conditions. The pharmacy manufactures the product, then tests it immediately (time 0), and then again at intervals (day 7, day 14, day 30, etc.) while storing samples at the assigned storage temperature (e.g., 2–8°C for refrigerated products). They document how potency changes over time, and from that data they assign a “beyond-use date”—the last date the product can be used while still meeting quality standards.

Without stability data, a pharmacy has to assign a conservative beyond-use date based on USP guidelines, which might be as short as 14 days for some reconstituted peptides. With stability data, they can justify a longer date—maybe 28–30 days—because they’ve actually tested the product and confirmed it remains potent through that window.

Why Stability Data Matters

If you receive a reconstituted peptide product with a 28-day beyond-use date, that date should be backed by stability data. If the pharmacy is just guessing based on general USP guidelines, and the product actually degrades faster, you might use it on day 25 thinking it’s still at 99% potency when it’s actually down to 80% potency. You won’t know—you’ll just think the product isn’t working.

Pharmaceutical manufacturers use stability data to support all beyond-use dates. Compounding pharmacies that do this are following the same quality standard.

Other Gold-Standard Tests

Beyond Potency Testing (BPT) can include:

• Container Closure Integrity Testing: For injectables in vials with rubber stoppers, this confirms the seal is airtight and won’t allow contamination or evaporation
• Environmental Monitoring: Routine testing of the compounding cleanroom’s air and surfaces for microbial contamination
• Process Validation: Documentation that the pharmacy’s manufacturing process reliably produces the correct product every time
• Forced Degradation Studies: Testing the product under intentionally harsh conditions (high heat, light) to understand its stability limits

Not all pharmacies do this level of testing, because it’s expensive and time-consuming. But it’s what pharmaceutical manufacturers do, and it’s the gold standard for quality assurance. If your pharmacy volunteers this information unprompted, that’s a strong quality signal.

Questions to Ask About Your Telehealth Provider’s Pharmacy

If you’re considering working with a telehealth provider, or if you already are, here are the key questions to ask about the pharmacy they use. These questions separate serious, quality-focused providers from those who are indifferent to pharmacy quality.

The Core Questions

1. “Which pharmacy compounds your peptides?”

They should name it immediately and provide location/contact info. If they’re vague or evasive, that’s suspicious. A serious provider knows exactly which pharmacy they work with and is proud of it.

2. “Is the pharmacy PCAB accredited or 503B registered?”

Either answer is acceptable, but they should have one or the other (or ideally both). If they say “neither,” ask why and what quality assurance measures they do have in place.

3. “Can I see a certificate of analysis for my specific product?”

The answer should be “yes, we provide CoAs with every order” or “yes, the pharmacy provides CoAs with every shipment.” If the answer is “no” or “we don’t usually do that,” stop there. You should always have access to testing data for your product.

4. “Does the pharmacy do sterility testing on every batch?”

For injectable products, the answer must be “yes.” This is not optional—sterile injectables must be tested for sterility. If they say “not on every batch” or “we rely on aseptic technique,” that’s a red flag.

5. “What is the assigned beyond-use date, and is it based on stability data?”

The answer reveals whether they do real stability testing or just use generic USP guidelines. A strong answer: “28 days under refrigeration, based on published stability data for [product name].” A weak answer: “14 days, per USP guidelines.”

6. “Does the pharmacy have any state board violations or FDA warning letters on file?”

A direct question might get a direct answer. You can also verify this yourself by checking state pharmacy board records and FDA enforcement actions online.

7. “Can you provide documentation of the pharmacy’s quality control processes?”

This might include summaries of their testing methods, cleanroom standards, personnel training, or quality management system. Serious pharmacies will have documentation they can share.

Red Flag Responses

If a provider responds with:

• “We don’t disclose which pharmacy we use” → Stop. You have a right to know.
• “CoAs are proprietary/confidential” → False. Your CoA is your quality document.
• “All compounded peptides are the same” → False. Quality varies tremendously.
• “We don’t need PCAB accreditation because we’re in [state]” → Evasive. If the pharmacy is good, they should have credentials to back it up.
• “Our pricing is so low because we’re efficient” → Sterile compounding is expensive. Prices that are drastically below market raise questions.

See What to Look for in a Peptide Telehealth Provider for a broader evaluation framework.

Red Flags in Compounding Pharmacy Quality

These are warning signs that suggest a pharmacy may not be maintaining quality standards:

Documentation Red Flags

• No CoA available, or CoA is not batch/lot specific. If you ask for a CoA and they provide a generic one not matched to your lot number, they haven’t actually tested your product.
• CoA lacking key test results. Missing sterility data, missing HPLC purity, or vague language like “passes specifications” instead of specific numbers.
• CoA with results outside specification but still deemed “acceptable.” This suggests quality control failures being accepted rather than investigated.

Pricing Red Flags

• Prices drastically below market. Sterile compounding requires equipment, trained staff, and testing. If a pharmacy is pricing at 20% of competitors, they may be cutting corners on quality—fewer tests, lower-grade materials, less rigorous process control.

Licensing and Compliance Red Flags

• No state pharmacy board license, or license suspended/revoked. This is disqualifying. Check your state board’s website.
• Pattern of state board violations. One minor violation is normal; a pattern of violations suggests systemic problems.
• FDA warning letters. The FDA posts warning letters to compounding pharmacies on FDA.gov when they find serious compliance issues. A warning letter is not disqualifying on its own (it can prompt improvement), but recent warning letters are a concern.
• No PCAB accreditation AND no 503B registration AND no mention of quality programs. A pharmacy in this category should at least have documentation of their quality processes. If they can’t or won’t provide it, they may not have one.

Product and Handling Red Flags

• Products shipped without proper cold chain. Peptides require specific temperature ranges. If shipments arrive warm or without temperature monitoring, the product integrity is compromised.
• Vials without proper labeling. Every vial should clearly show: compound name, concentration (mg/mL), volume, lot number, beyond-use date, and storage instructions. Missing or unclear labeling is unprofessional.
• Beyond-use dates that seem unreasonably long. A reconstituted peptide solution with a 90-day beyond-use date is suspicious unless backed by published stability data. Standard expectation: 14–30 days for reconstituted, longer for lyophilized.
• Inconsistent product appearance between orders. If you’ve received this product before and the new vial looks noticeably different (different color, cloudiness, crystal formation), something may have gone wrong.

If you encounter any of these red flags, discuss them with your provider or ask the pharmacy directly. If the responses don’t satisfy you, consider switching to a provider or pharmacy with stronger quality credentials.

The Cold Chain: Shipping and Storage Standards

Peptides are biological molecules—proteins and peptide fragments are sensitive to heat, light, and time. Proper storage is part of the quality assurance chain. If a pharmacy manufactures a perfect product but then ships it in a warm box, you receive a degraded product.

Lyophilized vs. Reconstituted

The storage requirements depend on the product form:

Lyophilized (freeze-dried) peptides: These are more stable. A lyophilized peptide can typically be stored at room temperature (15–25°C / 59–77°F) or refrigerated (2–8°C / 35–46°F) for months or even years, depending on the peptide and formulation. Heat and humidity are the main enemies. Lyophilized products should be shipped in insulated packaging with cold packs (though short temperature excursions during transit are generally tolerable).

Reconstituted (dissolved in solution) peptides: These are more fragile. A reconstituted peptide must be kept at 2–8°C (35–46°F)—always refrigerated. Even a few hours at room temperature can degrade the product. Any significant temperature excursion (leaving it out on the counter, shipping without cold packs) will reduce potency.

Shipping Standards

A quality pharmacy should:

• Use insulated, thermal packaging (styrofoam boxes or equivalent)
• Include appropriate cold packs (ice packs or gel packs) that maintain 2–8°C (35–46°F) for the duration of transit
• Use overnight or 2-day shipping to minimize time in transit
• Include temperature monitoring devices (optional but good practice)—these are small cards that change color if the shipment gets too warm, confirming the cold chain was maintained
• Provide tracking so you know when to expect delivery and can retrieve the shipment promptly

What to Do If Your Shipment Arrives Warm

If you receive a package that feels warm to the touch, or if cold packs have melted completely, contact the pharmacy immediately. Do not assume the product is still good. Depending on how long it was warm and what the product is, potency may be compromised. Ask the pharmacy for instructions—they may offer a replacement or ask you to return it for testing.

See Peptide Storage and Handling Guide for detailed storage instructions after you receive your product.

Frequently Asked Questions

How do I find out which pharmacy my telehealth provider uses?

Ask directly—it should be on your welcome materials or invoice, or you can email/call and request the pharmacy name and contact information. A quality provider will have this information readily available. If they’re evasive, that’s a red flag.

Is PCAB accreditation required for compounding pharmacies?

No, PCAB accreditation is entirely voluntary. However, it does signal that a pharmacy has committed to quality standards that exceed minimum state requirements. Many excellent pharmacies are not PCAB-accredited, so lack of accreditation is not disqualifying—but its presence is a positive signal.

What should I do if my provider won’t share the pharmacy’s certificate of analysis?

First, ask the pharmacy directly—they can provide CoAs to you independently of the provider. If both refuse, that’s a serious red flag. You have a right to quality documentation for the product you’re receiving and paying for. If a provider won’t provide CoAs, consider switching to one that will.

Are 503B outsourcing facilities better than 503A pharmacies?

Not necessarily “better,” but they do have higher baseline FDA oversight and manufacturing standards. A 503B facility is FDA-registered and inspected, and must meet cGMP standards. A well-run 503A pharmacy can produce equally high-quality products, but a 503A pharmacy requires more homework on your part to verify quality. If you can verify strong quality at a 503A pharmacy (PCAB accreditation, published stability data, full CoAs), it’s equally valid.

How do I check if a compounding pharmacy has any violations?

Start with your state pharmacy board’s website—each state has a public lookup tool where you can search by pharmacy name and view licensing status and any disciplinary actions. You can also search the FDA website (FDA.gov) for “warning letters” to compounding pharmacies. If you find violations, ask the pharmacy what corrective actions they took.

Can I choose which compounding pharmacy fills my prescription?

This depends on your telehealth provider’s contracts. Some providers use only one pharmacy; others have relationships with multiple. If your provider uses only one pharmacy and you have concerns about its quality, you can ask the provider if they’ll work with a different pharmacy, or you can switch to a provider that uses a pharmacy you trust more. Ultimately, your prescriber can send your prescription to any licensed pharmacy, but your telehealth provider may have a preferred pharmacy for their service model.

Why is compounded semaglutide so much cheaper than branded Ozempic?

Compounded semaglutide is cheaper because it’s not manufactured by Novo Nordisk, doesn’t have the same regulatory approval status, and doesn’t include Novo Nordisk’s R&D costs, marketing, and brand premium. A quality compounding pharmacy should still test semaglutide to confirm identity, purity, and concentration—but the economics are different from a branded drug. However, price should not be the only consideration. A $50 vial from a pharmacy with no testing and no credentials is a worse deal than a $150 vial from a PCAB-accredited pharmacy with full CoAs and published stability data.